" class="no-js "lang="en-US"> Carrum Health Appoints Randy K. Hawkins, M.D. as Chief Medical Officer - Medtech Alert
Monday, April 15, 2024

Carrum Health Appoints Randy K. Hawkins, M.D. as Chief Medical Officer

Carrum Health, the first value-based Centers of Excellence (COEs) platform for surgical care, today announced Randy K. Hawkins, M.D., FACHE as the company’s Chief Medical Officer (CMO). With nearly three decades of clinical experience as an anesthesiologist and senior healthcare technology executive, Dr. Hawkins will direct Carrum’s efforts to deliver the highest quality and most cost-effective care to its members.

As Carrum’s CMO, Dr. Hawkins will advance Carrum’s mission to provide rigorous analysis of providers and provider organizations and expand a world-class COE network across the country. Carrum’s COE partners represent the top 10% in their respective specialties and are evaluated at the individual surgeon level. Carrum COEs are given incentives to provide the most appropriate care in all cases, regardless of whether a patient has been recommended for surgical intervention by another physician. This results in 30% of Carrum members being redirected to less invasive, less costly care.

“Carrum is changing the way healthcare is delivered at its very core. We’re not building on top of a broken system; instead, we’ve reinvented the healthcare delivery model and created a system where patients are supported at every step of their health journey,” said Sach Jain, CEO and founder of Carrum Health. “Reimagining healthcare delivery requires a deep understanding of how to engage with patients, as well as the ability to help them navigate the complexities and breakdowns of our current system. Dr. Hawkins brings a unique blend of clinical leadership, provider and payer relationships, and analytics expertise to help us address the industry’s most challenging cost and quality issues.”

Before joining Carrum Health, Dr. Hawkins was CMO and Executive Vice President of Health Analytics at ConsumerMedical (acquired by Alight), a leading health concierge company, where he led a nationwide physician network and a team of actuaries in developing products to evaluate millions of providers across the U.S. In addition, he held Chief Medical and Chief Medical Information Officer roles at Connance Inc., Glytec and PatientKeeper Inc. Earlier in his career, he was a practicing anesthesiologist in private practice for 12 years. Dr. Hawkins was also a Medical Officer in the U.S. Navy and a decorated combat veteran of Operations Desert Shield and Desert Storm. He earned his B.A. in Biochemistry from Dartmouth College, his M.D. from Georgetown University School of Medicine and completed his residency training in anesthesiology at the University of Florida College of Medicine.

“I had the privilege of impacting many lives as an anesthesiologist, but I was ultimately drawn to the business side of healthcare, where I saw an opportunity to make an even greater impact to help rehabilitate the current model. This involves aligning quality care with reasonable costs – without ever losing sight of the patient experience,” said Dr. Hawkins. “Carrum is the first company I’ve seen that addresses both the cost and quality components of the healthcare equation. Carrum built a vehicle that is delivering true value-based care, and the talent and experience of this team are unparalleled in the industry. I am honored to join Carrum Health to help deliver the highest quality, best care for our members.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more